In the latest trading session, 1.87 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.51. With the company’s most recent per share price at $1.88 changing hands around $0.08 or 4.72% at last look, the market valuation stands at $8.07M. PSTV’s current price is a discount, trading about -170.74% off its 52-week high of $5.09. The share price had its 52-week low at $0.97, which suggests the last value was 48.4% up since then. When we look at Plus Therapeutics Inc’s average trading volume, we note the 3-month average coming to 30.13K.
Plus Therapeutics Inc (NASDAQ:PSTV) trade information
Instantly PSTV is in green as seen in intraday trades today. With action 13.55%, the performance over the past five days has been green. The jump to weekly highs of 1.9200 added 4.72% to the stock’s daily price. The company’s shares are showing year-to-date upside of 7.71%, with the 5-day performance at 13.55% in the green. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is 0.27% up.
Plus Therapeutics Inc (PSTV) estimates and forecasts
Data shows that the Plus Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 38.60% over the past 6 months, a 76.65% in annual growth rate that is considerably higher than the industry average of 11.70%. Year-over-year growth is forecast to reach 3.40% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 1.69M. 2 analysts are of the opinion that Plus Therapeutics Inc’s revenue for the current quarter will be 1.69M. The company’s revenue for the corresponding quarters a year ago was 506k and 790k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 234.00%. The estimates for the next quarter sales put growth at 113.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 68.20%. The 2024 estimates are for Plus Therapeutics Inc earnings to increase by 43.16%.
